Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 705 (USA) (Dr. Muller)
· consented 2013-09-16
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate DYSPEPSIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-17 (study day 2.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate DYSPEPSIA — outcome: RECOVERED/RESOLVED; onset 2013-09-17 (study day 2.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.